Cleared Traditional

Upper Arm Electronic Blood Pressure Monitor (K202372) - FDA 510(k) Clearance

Class II Cardiovascular device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

K202372 · Conmo Electronic Company Limited · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Dec 2020
Decision
133d
Days
Class 2
Risk

K202372 is an FDA 510(k) clearance for the Upper Arm Electronic Blood Pressure Monitor. Classified as System, Measurement, Blood-pressure, Non-invasive (product code DXN), Class II - Special Controls.

Submitted by Conmo Electronic Company Limited (Shenzhen City, CN). The FDA issued a Cleared decision on December 30, 2020 after a review of 133 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1130 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

View all Conmo Electronic Company Limited devices

Submission Details

510(k) Number K202372 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 19, 2020
Decision Date December 30, 2020
Days to Decision 133 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
8d slower than avg
Panel avg: 125d · This submission: 133d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DXN System, Measurement, Blood-pressure, Non-invasive
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1130
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Consultant

International Regulatory Consultants
Charlie Mack

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DXN System, Measurement, Blood-pressure, Non-invasive

All 285
Devices cleared under the same product code (DXN) and FDA review panel - the closest regulatory comparables to K202372.
Blood Pressure Monitor
K202934 · Bioland Technology, Ltd. · Jan 2021
EV1000 Clinical Platform Non-Invasive (NI) or ClearSight System, EV1000 Clinical Platform
K203131 · Edwards Lifesciences, LLC · Jan 2021
InBody
K200560 · Inbody Co., Ltd. · Jan 2021
Wrist Type Blood Pressure Monitor
K200346 · Avita Corporation · Dec 2020
Transtek Wrist Blood Pressure Monitor
K202599 · Guangdong Transtek Medical Electronics Co., Ltd. · Dec 2020
InBody
K200442 · Inbody Co., Ltd. · Dec 2020